does semaglutide work better than tirzepatide for some people Cardiovascular outcomes of and patients with type 2 diabetes in clinical practice Semaglutide vs Tirzepatide: Complete Comparison

TZP: tirzepatide

1 REIMAGINE 2 was a 68-week phase 3 trial evaluating the safety and efficacy of CagriSema in doses 2.4 mg/2.4 mg and 1 mg/1 mg once weekly versus semaglutide 2.4 mg, semaglutide 1 mg, cagrilintide 2.4 mg, and dose-matched placebo in 2,713 adults with T2D inadequately controlled with metformin with or without an SGLT2 inhibitor

These medications reduce cardiovascular adverse events for type 2 diabetics with an established cardiovascular disease or who are at high risk of cardiovascular disease

Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes